Carbacaprazamycins, which are chemically stable analogues of caprazamycins, were designed and synthesized. These analogues were active against drug-resistant bacterial pathogens such as methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci, and their activities were comparable to those of the parent caprazamycins. The effect of treatment with carbacaprazamycin on morphological changes in S. aureus indicated that the mode of action was completely different from those of existing peptidoglycan inhibitors.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/id5000376 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!